Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upper Limbs”

15,880 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 15,880 results

Early research (Phase 1)Active Not RecruitingNCT04877717
What this trial is testing

SHR-A1904 in Patients With Advanced Solid Cancer

Who this might be right for
Advanced Solid Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 107
Testing effectiveness (Phase 2)Study completedNCT02544997
What this trial is testing

A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway

Who this might be right for
Metastatic Breast Cancer
Samsung Medical Center 5
Not applicableUnknownNCT03547310
What this trial is testing

PlayBionic: Interactive Mobile Training App

Who this might be right for
Rehabilitation
Medical University of Vienna 8
Testing effectiveness (Phase 2)Study completedNCT02259582
What this trial is testing

Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
OncoMed Pharmaceuticals, Inc. 82
Post-approval studies (Phase 4)Not Yet RecruitingNCT06245824
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 51
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06680596
What this trial is testing

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Who this might be right for
Breast Cancer MetastaticBreast Cancer Stage IV
UNICANCER 80
Large-scale testing (Phase 3)Study completedNCT00775203
What this trial is testing

A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

Who this might be right for
Major Depressive Disorder
Labopharm Inc. 412
Testing effectiveness (Phase 2)Study completedNCT04615403
What this trial is testing

Study of Exchange of Travoprost Intraocular Implant

Who this might be right for
Open Angle Glaucoma
Glaukos Corporation 33
Not applicableLooking for participantsNCT06989073
What this trial is testing

Effect of Muscle Energy Technique in Children With Post Traumatic Elbow Stiffness

Who this might be right for
Elbow Injuries
Cairo University 38
Not applicableStudy completedNCT03131960
What this trial is testing

Pivotal Study of VNS During Rehab After Stroke (VNS-REHAB)

Who this might be right for
Cerebrovascular StrokeUpper Extremity Paresis
MicroTransponder Inc. 108
Testing effectiveness (Phase 2)UnknownNCT05371223
What this trial is testing

Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases

Who this might be right for
Peritoneal CarcinomatosisPancreas Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Testing effectiveness (Phase 2)Study completedNCT05217303
What this trial is testing

HL-085 in NRAS-mutated Advanced Melanoma

Who this might be right for
Melanoma
Shanghai Kechow Pharma, Inc. 100
Not applicableStudy completedNCT01158261
What this trial is testing

The Evicel Post-Authorization Surveillance Study

Who this might be right for
Peripheral Vascular DiseaseHemorrhage
Ethicon, Inc. 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07753642
What this trial is testing

Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma

Who this might be right for
Nodal T-follicular Helper Cell Lymphoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Study completedNCT03895970
What this trial is testing

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Who this might be right for
Liver Neoplasm Malignant PrimaryCholangiocarcinomaCombinational Immunotherapy+1 more
Peking Union Medical College Hospital 32
Large-scale testing (Phase 3)Study completedNCT01406470
What this trial is testing

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Who this might be right for
Immunologic Deficiency Syndrome
Green Cross Corporation 45
Not applicableUnknownNCT05925673
What this trial is testing

Early NMES and Mirror Therapy Interventions During Immobilization of Distal Radius Fracture

Who this might be right for
Distal Radius Fracture
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07329569
What this trial is testing

Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial

Who this might be right for
Chemical BurnsOcular Burns
Fondation Ophtalmologique Adolphe de Rothschild 21
Post-approval studies (Phase 4)Study completedNCT01885091
What this trial is testing

Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage

Who this might be right for
Skin RoughnessMottlingBlotchiness+2 more
Menarini (Thailand) Limited 100
Not applicableLooking for participantsNCT07234110
What this trial is testing

CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors

Who this might be right for
Relapsed and Refractory CD5 Hematological Tumors
Institute of Hematology & Blood Diseases Hospital, China 18
Next Page